These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 15386590

  • 1. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis.
    Fairweather D, Frisancho-Kiss S, Rose NR.
    Rev Med Virol; 2005; 15(1):17-27. PubMed ID: 15386590
    [Abstract] [Full Text] [Related]

  • 2. From infection to autoimmunity.
    Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR.
    J Autoimmun; 2001 May; 16(3):175-86. PubMed ID: 11334481
    [Abstract] [Full Text] [Related]

  • 3. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
    Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, Sarvetnick N.
    Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
    [Abstract] [Full Text] [Related]

  • 4. The innate immune response: an important partner in shaping coxsackievirus-mediated autoimmunity.
    Richer MJ, Horwitz MS.
    J Innate Immun; 2009 Jun; 1(5):421-34. PubMed ID: 20375600
    [Abstract] [Full Text] [Related]

  • 5. Immunopathogenesis of experimental Coxsackievirus induced myocarditis: role of autoimmunity.
    Huber SA, Lyden DC, Lodge PA.
    Herz; 1985 Feb; 10(1):1-7. PubMed ID: 2984097
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of myocarditis and dilated cardiomyopathy.
    Cihakova D, Rose NR.
    Adv Immunol; 2008 Feb; 99():95-114. PubMed ID: 19117533
    [Abstract] [Full Text] [Related]

  • 7. Toll-like receptor 4-induced cytokine production circumvents protection conferred by TGF-beta in coxsackievirus-mediated autoimmune myocarditis.
    Richer MJ, Fang D, Shanina I, Horwitz MS.
    Clin Immunol; 2006 Dec; 121(3):339-49. PubMed ID: 16963319
    [Abstract] [Full Text] [Related]

  • 8. Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?
    Qian Q, Xiong S, Xu W.
    Future Microbiol; 2012 Oct; 7(10):1207-16. PubMed ID: 23030425
    [Abstract] [Full Text] [Related]

  • 9. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent.
    Triantafilou K, Orthopoulos G, Vakakis E, Ahmed MA, Golenbock DT, Lepper PM, Triantafilou M.
    Cell Microbiol; 2005 Aug; 7(8):1117-26. PubMed ID: 16008579
    [Abstract] [Full Text] [Related]

  • 10. Autoimmunity in coxsackievirus B3 induced myocarditis.
    Huber SA.
    Autoimmunity; 2006 Feb; 39(1):55-61. PubMed ID: 16455582
    [Abstract] [Full Text] [Related]

  • 11. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M, Merkle I, Klingel K, Hammerschmidt E, Zautner AE, Wutzler P.
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [Abstract] [Full Text] [Related]

  • 12. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
    Henke A, Jarasch N, Martin U, Wegert J, Wildner A, Zell R, Wutzler P.
    Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
    [Abstract] [Full Text] [Related]

  • 13. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
    Jiang Z, Xu W, Li K, Yue Y, Xu L, Ye F, Xiong S.
    J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
    [Abstract] [Full Text] [Related]

  • 14. Adjuvants and autoimmunity.
    Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y.
    Lupus; 2009 Nov; 18(13):1217-25. PubMed ID: 19880572
    [Abstract] [Full Text] [Related]

  • 15. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
    Yue Y, Xu W, Hu L, Jiang Z, Xiong S.
    Virology; 2009 Apr 10; 386(2):438-47. PubMed ID: 19233446
    [Abstract] [Full Text] [Related]

  • 16. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 10; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 17. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J, Liu Z, Lim T, Zhang H, He J, Walker E, Shier C, Wang Y, Su Y, Sall A, McManus B, Yang D.
    Circ Res; 2009 Mar 13; 104(5):628-38. PubMed ID: 19168435
    [Abstract] [Full Text] [Related]

  • 18. Induction of antigen specific peripheral humoral tolerance to cardiac myosin does not prevent CB3-mediated autoimmune myocarditis.
    Horwitz MS, Ilic A, Fine C, Sarvetnick N.
    J Autoimmun; 2005 Sep 13; 25(2):102-11. PubMed ID: 16011890
    [Abstract] [Full Text] [Related]

  • 19. Viral damage or 'molecular mimicry'-placing the blame in myocarditis.
    Rose NR.
    Nat Med; 2000 Jun 13; 6(6):631-2. PubMed ID: 10835674
    [No Abstract] [Full Text] [Related]

  • 20. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection.
    Fairweather D, Frisancho-Kiss S, Gatewood S, Njoku D, Steele R, Barrett M, Rose NR.
    Autoimmunity; 2004 Mar 13; 37(2):131-45. PubMed ID: 15293883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.